0001562180-19-006265.txt : 20191226 0001562180-19-006265.hdr.sgml : 20191226 20191226161154 ACCESSION NUMBER: 0001562180-19-006265 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20191224 FILED AS OF DATE: 20191226 DATE AS OF CHANGE: 20191226 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ZDRAVESKI ZORAN CENTRAL INDEX KEY: 0001741285 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38541 FILM NUMBER: 191310690 MAIL ADDRESS: STREET 1: C/O MAGENTA THERAPEUTICS STREET 2: 50 HAMPSHIRE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Magenta Therapeutics, Inc. CENTRAL INDEX KEY: 0001690585 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 TECHNOLOGY SQUARE STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 BUSINESS PHONE: 857-201-2700 MAIL ADDRESS: STREET 1: 100 TECHNOLOGY SQUARE STREET 2: 5TH FLOOR CITY: CAMBRIDGE STATE: MA ZIP: 02139 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2019-12-24 false 0001690585 Magenta Therapeutics, Inc. MGTA 0001741285 ZDRAVESKI ZORAN C/O MAGENTA THERAPEUTICS, INC. 50 HAMPSHIRE STREET CAMBRIDGE MA 02139 false true false false See Remarks Common Stock 2019-12-24 4 S false 7902.00 16.00 D 128009.00 D This trade is pursuant to an active 10b5-1 plan. This transaction was executed in multiple trades at prices ranging from $16.00 to $16.10. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Secretary and Chief Legal Officer /s/Zoran Zdraveski 2019-12-26